FDA panel backs first multi-cancer blood test: What to know

The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee voted Sept. 23 in favor of approving Grail’s Galleri multi-cancer early-detection blood test. The vote marks the first time a test of this kind has reached this stage. The panel voted 7-2, with one abstention, that the test’s benefits outweigh its risks […] The post FDA panel backs first multi-cancer blood test: What to know appeared first on Becker's Hospital Review | Healthcar...